Summary
Results from the Aldosterone Receptor Blockade in Diastolic Heart Failure [Aldo-DHF; ISCRTN94726526] trial showed that spironolactone significantly improves diastolic function and blood pressure control, but not exercise capacity, in patients with diastolic heart failure.
- Heart Failure
- Hypertensive Disease
- Cardiology Clinical Trials
- © 2012 MD Conference Express®
Tools
Results from the Aldo-DHF Trial
Permalink:
